B-lymphoid tyrosine kinase (Blk) is an oncogene and a potential target for therapy with dasatinib in cutaneous T-cell lymphoma (CTCL)

Leukemia. 2014 Oct;28(10):2109-12. doi: 10.1038/leu.2014.192. Epub 2014 Jun 12.

¹ Department of International Health, Immunology and Microbiology, University of Copenhagen, Copenhagen, Denmark.
² Center for Cancer Immune Therapy (CCIT), Department of Hematology, Herlev University Hospital, Herlev, Denmark.
³ Proteomics Program, NNF Center for Protein Research, University of Copenhagen, Copenhagen, Denmark.
⁴ Lymphoma Diagnosis and Treatment Center, Department of Oncology, First Affiliated Hospital of Zhengzhou University, Henan, China.
⁵ Department of Pathology and Laboratory Medicine, University of Pennsylvania, Philadelphia, PA, USA.

No abstract available

Publication types